We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: insulin resistance
MedXY News
EnglishTag

insulin resistance

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Reevaluating the Link Between Helicobacter pylori Infection and Insulin Resistance: Insights from Frequentist and Bayesian Analyses in a European Cohort
Diabetes & Endocrinologymetabolic syndromeHelicobacter pylori

Reevaluating the Link Between Helicobacter pylori Infection and Insulin Resistance: Insights from Frequentist and Bayesian Analyses in a European Cohort

By MedXY|Aug 25, 2026

A comprehensive European cohort study reveals that Helicobacter pylori infection’s association with insulin resistance is confounded by socioeconomic and lifestyle factors, arguing against its independent causal role and the need for

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function
Cardiologyepidemiologydiabetes

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function

By MedXY|Aug 13, 2026

This study reveals a high heart failure risk within 5 years of diabetes diagnosis, highlighting insulin resistance and reduced kidney function as independent predictors beyond conventional risk factors.

Elevated Endogenous Insulin and Insulin Resistance in Progressive Diastolic Dysfunction and Cardiovascular Risk: A Comprehensive Clinical Review
Cardiologydiastolic dysfunctionheart failure with preserved ejection fraction

Elevated Endogenous Insulin and Insulin Resistance in Progressive Diastolic Dysfunction and Cardiovascular Risk: A Comprehensive Clinical Review

By MedXY|Aug 11, 2026

Elevated endogenous insulin and insulin resistance independently predict progression of diastolic dysfunction and increased cardiovascular mortality, highlighting early metabolic dysregulation as a target to prevent heart failure with prese

Adolescent MASLD Plus PCOS Signals a Higher-Risk Cardiometabolic Trajectory Into Adulthood
Diabetes & Endocrinologycardiometabolic riskinsulin resistance

Adolescent MASLD Plus PCOS Signals a Higher-Risk Cardiometabolic Trajectory Into Adulthood

By MedXY|May 28, 2026

In the Raine Study, adolescents with both MASLD and PCOS had a substantially worse cardiometabolic profile by age 27 than peers with either condition alone, highlighting a high-risk subgroup that may warrant earlier metabolic surveillance.

Prepregnancy Insulin Resistance and Fertility Outcomes in Women With PCOS
Diabetes & EndocrinologyPCOSfertility

Prepregnancy Insulin Resistance and Fertility Outcomes in Women With PCOS

By MedXY|Aug 18, 2026

Higher insulin resistance before pregnancy was linked to poorer ovulation, lower pregnancy and live-birth rates, and more gestational diabetes in women with PCOS. Improving insulin resistance during treatment was associated with better preg

Children Born SGA Receiving Growth Hormone Have Similarly Impaired Glucose-Insulin Metabolism as Children With Obesity
Diabetes & Endocrinologyendocrinologygrowth hormone therapy

Children Born SGA Receiving Growth Hormone Have Similarly Impaired Glucose-Insulin Metabolism as Children With Obesity

By MedXY|May 19, 2026

Children born SGA receiving growth hormone showed insulin resistance and prediabetes rates similar to obesity, suggesting the need for careful glucose monitoring during and after treatment.

Weight Regain Can Reverse the Metabolic Benefits of Caloric Restriction: Insights From CALERIE-2
Diabetes & EndocrinologyCaloric RestrictionIGF-1

Weight Regain Can Reverse the Metabolic Benefits of Caloric Restriction: Insights From CALERIE-2

By MedXY|May 13, 2026

CALERIE-2 post hoc analysis found that weight regain after caloric restriction can reverse improvements in insulin and IGF-1 signaling, while sustained weight loss preserves metabolic benefits and may lower biological aging markers.

Oral Glucose Absorption Enhanced in Early Metabolic Dysfunction-Associated Steatotic Liver Disease
Diabetes & Endocrinologyglucose absorptioninsulin resistance

Oral Glucose Absorption Enhanced in Early Metabolic Dysfunction-Associated Steatotic Liver Disease

By MedXY|Apr 30, 2026

New research reveals accelerated glucose absorption in early MASLD patients, independent of gastric emptying. This metabolic alteration may drive liver disease progression before hepatic insulin resistance develops.

Early MASLD Is Associated With Enhanced Oral Glucose Absorption Independent of Gastric Emptying
Diabetes & Endocrinologyinsulin resistanceMASLD

Early MASLD Is Associated With Enhanced Oral Glucose Absorption Independent of Gastric Emptying

By MedXY|Apr 30, 2026

Stable-isotope OGTT data suggest that early MASLD is linked to higher oral glucose absorption, independent of gastric emptying, with preserved hepatic insulin suppression but impaired peripheral glucose clearance.

Surgical Metabolic Intervention: Bariatric Surgery Transforms Outcomes in Type 1 Diabetes With Obesity
Diabetes & EndocrinologyGlycemic Controlinsulin resistance

Surgical Metabolic Intervention: Bariatric Surgery Transforms Outcomes in Type 1 Diabetes With Obesity

By MedXY|Apr 13, 2026

A multicenter retrospective cohort study reveals that metabolic bariatric surgery in 162 adults with type 1 diabetes and obesity achieved 29.7% weight loss at one year, reduced insulin requirements by 57%, and significantly improved glycemi

Insulin Resistance and Hyperinsulinemia: The Hidden Drivers of Lung Function Decline in Diabetes
Diabetes & EndocrinologydiabetesFEV1

Insulin Resistance and Hyperinsulinemia: The Hidden Drivers of Lung Function Decline in Diabetes

By MedXY|Mar 20, 2026

A comprehensive study combining the German Diabetes Study data and Mendelian randomization establishes a causal link between insulin resistance and reduced lung function (FEV1 and FVC), positioning the lung as a critical target for metaboli

OGTT-Derived Surrogate Indexes Outperform Fasting Measures in Predicting Type 2 Diabetes Risk: A Longitudinal Analysis
Diabetes & Endocrinologyinsulin resistanceOGTT

OGTT-Derived Surrogate Indexes Outperform Fasting Measures in Predicting Type 2 Diabetes Risk: A Longitudinal Analysis

By MedXY|Mar 10, 2026

A longitudinal study of 2,260 participants confirms that oral glucose tolerance test (OGTT)-based surrogate indexes, particularly Gutt and Cederholm, are superior to fasting-only measures in predicting type 2 diabetes, providing high clinic

Insulin Resistance Blunts LVAD-Mediated Myocardial Recovery by Impairing the Pentose Phosphate Pathway
Cardiologyheart failureinsulin resistance

Insulin Resistance Blunts LVAD-Mediated Myocardial Recovery by Impairing the Pentose Phosphate Pathway

By MedXY|Mar 2, 2026

Obesity-induced insulin resistance hinders heart failure recovery post-LVAD by disrupting the pentose phosphate pathway. A new study in Circulation suggests insulin sensitizers could restore cardiac repair mechanisms in obese patients.

Beyond Blood Sugar: Why Insulin Resistance Drives Vagal Dysfunction in Heart Failure
Cardiologyautonomic functionheart failure

Beyond Blood Sugar: Why Insulin Resistance Drives Vagal Dysfunction in Heart Failure

By MedXY|Feb 4, 2026

Evidence from the Myovasc study reveals that insulin resistance and C-peptide levels are independent predictors of impaired cardiac vagal activity in heart failure, suggesting that metabolic health directly influences autonomic regulation b

Insulin Metabolism as a Primary Driver of Cardiac Autonomic Dysfunction in Heart Failure: Insights from the Myovasc Study
Cardiologyautonomic nervous systemheart failure

Insulin Metabolism as a Primary Driver of Cardiac Autonomic Dysfunction in Heart Failure: Insights from the Myovasc Study

By MedXY|Feb 3, 2026

The Myovasc study demonstrates that insulin resistance and secretion markers, rather than glucose levels alone, are independently associated with impaired cardiac vagal activity in heart failure patients, suggesting a metabolic-autonomic ax

High Insulin Resistance Blunts the Superiority of Ticagrelor Over Clopidogrel in Minor Stroke Patients with CYP2C19 Mutations
Diabetes & EndocrinologyAntiplatelet TherapyCYP2C19

High Insulin Resistance Blunts the Superiority of Ticagrelor Over Clopidogrel in Minor Stroke Patients with CYP2C19 Mutations

By MedXY|Jan 22, 2026

A post hoc analysis of the CHANCE-2 trial suggests that the clinical benefit of ticagrelor over clopidogrel for secondary stroke prevention in CYP2C19 loss-of-function carriers is significantly attenuated in patients with high insulin resis

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone
Diabetes & Endocrinologyinsulin resistanceliraglutide

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone

By MedXY|Nov 17, 2025

A 2025 meta-analysis of 19 RCTs (n=1657) found liraglutide combined with metformin improved glycaemia, insulin resistance, BMI, sex hormones and lipids versus metformin alone in overweight or obese women with PCOS; evidence certainty was lo

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone
Diabetes & Endocrinologyinsulin resistanceliraglutide

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone

By MedXY|Nov 17, 2025

A 2025 meta-analysis of 19 RCTs (n=1657) found liraglutide combined with metformin improved glycaemia, insulin resistance, BMI, sex hormones and lipids versus metformin alone in overweight or obese women with PCOS; evidence certainty was lo

Triglyceride Glucose-Waist Height Ratio Index as a Predictor of Cardiometabolic Multimorbidity in Chinese Middle-Aged and Older Adults: Insights from a National Prospective Cohort Study
CardiologyCardiometabolic multimorbidityCentral Adiposity

Triglyceride Glucose-Waist Height Ratio Index as a Predictor of Cardiometabolic Multimorbidity in Chinese Middle-Aged and Older Adults: Insights from a National Prospective Cohort Study

By MedXY|Oct 19, 2025

This study demonstrates that the triglyceride glucose-waist height ratio (TyG-WHtR) index independently predicts cardiometabolic multimorbidity risk in Chinese adults aged ≥45, showing a linear dose-response relationship and improved predic

Joint Impact of TyG-Related Indices and eGDR on Cardiometabolic Multimorbidity Risk in Chinese Adults: Insights from a Nationwide Cohort
CardiologyCardiometabolic multimorbidityinsulin resistance

Joint Impact of TyG-Related Indices and eGDR on Cardiometabolic Multimorbidity Risk in Chinese Adults: Insights from a Nationwide Cohort

By MedXY|Oct 19, 2025

This study elucidates that high triglyceride glucose (TyG) related indices combined with low estimated glucose disposal rate (eGDR) synergistically elevate cardiometabolic multimorbidity (CMM) risk in middle-aged and older Chinese adults, e

1 / 2
12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story